Table I.
Baseline demographic and clinical characteristics of the 30 patients.
| Characteristic | Demographics |
|---|---|
| Males, n (%) | 16 (53.3) |
| Age, years | 70.1±10.7 |
| BMI | 24.4±4.42 |
| WBC (/µl) | 4,346.7±1,515.8 |
| Hb (g/dl) | 12.4±2.02 |
| PLT (x104 /µl) | 9.93±4.98 |
| PT (%) | 79.3±14.8 |
| ALB (g/dl) | 3.24±0.54 |
| T-BIL (mg/dl) | 1.14±0.5 |
| AST (U/l) | 58.8±36.0 |
| ALT (U/l) | 32.6±38.7 |
| GGT (U/l) | 53.6±39.6 |
| FPG (mg/dl) | 107.9±25.1 |
| Insulin (units) | 17.3±22.2 |
| HbA1c (%) | 5.54±1.12 |
| GA (%) | 19.6±4.98 |
| 1,5-AG (µg/ml) | 18.8±9.8 |
| Glycemic parameters obtained from CGMS | |
| Average BG (mg/dl) | 142±38.7 |
| Maximum BG (mg/dl) | 209.3±65.7 |
| Minimum BG (mg/dl) | 85.1±25.4 |
| Child-Pugh score, n (%) | |
| 5 | 10 (33.3) |
| 6 | 8 (26.7) |
| 7 | 7 (23.3) |
| 8 | 5 (16.7) |
| Etiology, n (%) | |
| HBV | 3 (10) |
| HCV | 19 (63.3) |
| NASH | 5 (16.7) |
| Alcohol | 2 (6.7) |
| Unknown | 1 (3.3) |
BMI, body mass index; WBC, white blood cell; Hb, hemoglobin; PLT, platelets; PT, prothrombin time; ALB, albumin; T-BIL, total bilirubin; AST, asparatate aminotransferase; ALT, alanine aminotransferase; GGT, γ-guanosine triphosphate cyclohydrolase; GA, glycoalbumin; 1,5-AG, 1,5-anhydroglucitol; FPG, fasting plasma glucose; HBV, hepatitis B virus; HCV, hepatitis C virus; NASH, non-alcoholic steatohepatitis; BG, blood glucose; CGMS, continuous glucose monitoring system.